{"id":"W2795475769","doi":"10.1186/s12885-018-4275-z","title":"Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Genome British Columbia","funders":"Vlaamse regering; European Society for Medical Oncology; Fonds Wetenschappelijk Onderzoek; Janssen Pharmaceuticals; American Association for Cancer Research; Waalse Gewest; European Regional Development Fund; European Organisation for Research and Treatment of Cancer","keywords":"Medicine; Prostate cancer; Prostatectomy; Urology; Placebo; Clinical endpoint; Antiandrogen; Androgen deprivation therapy; Internal medicine; Androgen receptor; Oncology; Randomized controlled trial; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001143027,0.0006012437,0.002213279,0.0002331949,0.0003470693,0.0001463702,0.0001794205,0.0002194632,0.0003038226],"category_scores_gemma":[0.0003369463,0.0003226318,0.000298952,0.0003390122,0.001224818,0.0001881189,0.00008177089,0.0004260465,0.00001089903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000449358,"about_ca_system_score_gemma":0.002256896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003535602,"about_ca_topic_score_gemma":0.005015802,"domain_scores_codex":[0.9962079,0.0002385006,0.0008568586,0.0009767541,0.0006945956,0.001025397],"domain_scores_gemma":[0.99732,0.0007415406,0.0005106633,0.000413922,0.0004583705,0.0005554943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9797166,0.0002881803,0.005952389,0.0003130709,0.00146643,0.0000312768,0.0009576824,0.000007968552,0.00038214,0.00001338059,0.005114611,0.0057563],"study_design_scores_gemma":[0.9765577,0.006189891,0.00006062109,0.0006444345,0.002065357,0.00002249576,0.0001414186,0.002701779,0.005147446,0.00006436338,0.005937234,0.0004672248],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.953991,0.005818894,0.0008700474,0.0009034124,0.0008207017,0.03683588,0.000411309,0.0001616231,0.0001871523],"genre_scores_gemma":[0.9152542,0.007093424,0.001516274,0.0002627637,0.001518674,0.05365076,0.0001519612,0.0001661606,0.02038583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03873682,"threshold_uncertainty_score":0.9999226,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02400971476274088,"score_gpt":0.3376450807353841,"score_spread":0.3136353659726432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}